GEN Exclusives

More »

GEN News Highlights

More »
Jan 12, 2010

Roche Taps Kinaxo for Phosphoproteomics Technology

  • Kinaxo Biotechnologies will apply its phosphoproteomics technology PhosphoScout® to support targeted treatment approaches currently under development at Roche Diagnostics. PhosphoScout enables the identification of regulated protein phosphorylation sites in response to therapeutic antibody or kinase-inhibitor treatment, according to Kinaxo.

    Using quantitative mass spectrometry, up to 15,000 phosphorylation sites can be monitored in a single experiment, the company claims. This facilitates analysis of the phosphoproteome in patient samples, animal models, and cell culture on a global scale.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?